Big banner Moscow.jpg

Cellthera Clinic, Brno, Czech Republic

Clinic Cellthera is one of the most prestigious clinics in the Czech Republic, located in the city of Brno and is engaged in innovative treatment methods.

The clinic represents a unique team of specialists, which includes doctors, scientists and researchers with 15 years of experience in the field of stem cell therapy, dendritic cell immunotherapy, many types of cell treatment and medical procedures that can be used in regenerative medicine to improve or solve problems associated with with health.

To date, Cellthera Clinic has cured nearly 3,000 patients using their own stem cells.

Stem Cell Therapy and Laser Therapies

Cellthera Clinic focuses on the use of stromal vascular fraction (SVF) cells rich in mesenchymal stem cells, other regenerative cells and growth factors important for tissue regeneration. SVF cells are obtained from the patient’s own fat using a minimally invasive procedure called mini-liposuction under local anesthesia.

The patented technology for obtaining the highest quality SVF cells containing stem cells is used in the medical practice of the clinic’s doctors - clinical specialists who have been trained and have the appropriate certificates.

The clinic treats the following diseases using stem cell therapy, as well as using laser therapies using soft laser types:

  • Orthopedics and traumatology
  • Cardiovascular diseases
  • Neurological diseases
  • Eye diseases (including optic atrophy)
  • Lung diseases
  • Urology
  • Gastroenterology
  • Diabetes and Autoimmune Diseases
  • Anti-aging therapy, plastic and aesthetic surgery

Cancer Immunotherapy by Dendritic cells

Cellthera experts, in collaboration with several European universities and the biotechnology industry, have developed a unique and patented anti-cancer vaccine derived from the patient's own immune cells, which can be easily obtained from peripheral blood. These cells are cultured invitro to produce dendritic cells.

Dendritic cells are professional cells of the immune system that can cause strong anti-cancer reactions. In some cases, it is also useful to obtain recently removed tumor tissue from a patient undergoing elective surgery.

Thus, the vaccine is directly adapted for each individual patient. In the case when autologous tumor tissue is not available, allogeneic tumor cell lines characterized by the presence of universal tumor-associated antigens can be provided as a source of tumor antigen.

In general, there are no serious side effects associated with the administration of the vaccine. The patient's quality of life can improve significantly. This type of vaccine can also be produced and administered at earlier stages of cancer to enhance the activation of its own immune system in the fight against tumor cells without significant side effects.

Cellthera's clinical specialists have over 15 years of experience in cancer immunotherapy. Dendritic cell vaccines may be made for clinical use in accordance with good manufacturing practice.

The following types of cancer are treated with this therapy:

  • Mammary cancer
  • Lungs' cancer
  • Stomach cancer
  • Head and neck cancer
  • Colorectal cancer
  • Kidney cancer
  • Prostate cancer
  • Cervical cancer
  • Ovarian cancer
  • Skin Cancer - Melanoma
  • Sarcoma - soft tissue sarcoma, Ewing's sarcoma, osteosarcoma
  • Brain Cancer - Glioblastoma
  • Childhood cancer

Send Request: